Neointima characteristics as a prognostic marker for drug-coated balloon angioplasty in patients with in-stent restenosis: an optical coherence tomography study

被引:4
|
作者
Kim, Hyung Oh [1 ]
Jung, Hae Won [2 ]
Lee, Jung-Hee [3 ]
Kim, Jung-Sun [4 ,5 ]
Hong, Sung-Jin [4 ,5 ]
Ahn, Chul-Min [4 ,5 ]
Kim, Byeong-Keuk [4 ,5 ]
Kim, Weon [1 ]
Kim, Soo-Joong [1 ]
Kim, Woong [3 ]
Ko, Young-Guk [4 ,5 ]
Choi, Donghoon [4 ,5 ]
Hong, Myeong-Ki [4 ,5 ]
Jang, Yangsoo [4 ,5 ,6 ]
机构
[1] Kyung Hee Univ, Dept Cardiol, Seoul, South Korea
[2] Daegu Catholic Univ, Dept Cardiol, Med Ctr, Gyongsan, South Korea
[3] Yeungnam Univ, Dept Cardiol, Med Ctr, Coll Med, Gyongsan, South Korea
[4] Yonsei Univ, Div Cardiol, Dept Internal Med, Coll Med, Seoul, South Korea
[5] Yonsei Univ, Cardiovasc Inst, Coll Med, Seoul, South Korea
[6] Yonsei Univ, Severance Biomed Sci Inst, Coll Med, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
drug-coated balloon; in-stent restenosis; neointima; optical coherence tomography; TISSUE CHARACTERISTICS; NEOATHEROSCLEROSIS; PATTERNS;
D O I
10.1097/MCA.0000000000000946
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Research has shown that the prognosis of in-stent restenosis (ISR) lesions after drug-coated balloon (DCB) angioplasty can differ in relation to in-stent neointimal characteristics. However, changes in neointima characteristics after DCB have not been studied. This study sought to investigate changes in neointima characteristics after DCB for ISR. Methods From the Yonsei Optical Coherence Tomography (OCT) registry, data on DCBs performed in patients with ISR were collected. Neointima characteristics were categorized as homogeneous, heterogeneous, layered neointima, and neoatherosclerosis in each OCT procedure. Homogeneous and layered neointima were classified as a favorable neointima, while heterogeneous neointima and neoatherosclerosis were classified as an unfavorable neointima. The data of 67 ISR patients were analyzed. Results The median duration between initial and follow-up OCT was 9.6 months. Patients with homogeneous and layered neointima on the initial OCT before DCB mostly appeared as homogeneous (66.7 and 68.2%, respectively) on the follow-up OCT, whereas most of the patients with heterogeneous neointima on the initial OCT remained unaltered (70%). Patients with unfavorable neointima at either the initial (P = 0.023) or the follow-up OCT (P = 0.037) had a worse major adverse cardiovascular event-free survival than the other patients. Patients who showed unfavorable neointima at both the initial and the follow-up OCT had the worst event-free survival (P = 0.038). Conclusions The follow-up OCT neointimal characteristics after DCB for ISR was associated with initial OCT characteristics. Sustained unfavorable neointima in serial OCT imaging may reflect poor prognosis in patients with ISR treated with DCB.
引用
收藏
页码:694 / 702
页数:9
相关论文
共 50 条
  • [21] Serial optical coherence tomography and angioscopic assessments of 10-year in-stent restenosis of Cypher sirolimus-eluting stent treated with drug-coated balloon angioplasty
    Suzuki, Satoshi
    Nakatani, Shimpei
    Sotomi, Yohei
    Shiojima, Ichiro
    Sakata, Yasushi
    Higuchi, Yoshiharu
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (01)
  • [22] Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis
    Cai, Xiaoqing
    Tian, Feng
    Jing, Jing
    Jin, Qinhua
    Zhou, Shanshan
    Yin, Weijun
    Chen, Yufang
    Wu, Qiang
    Fu, Zhenhong
    Chen, Yundai
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2021, 97 : 1048 - 1054
  • [23] Late Stent Thrombosis After Drug-Coated Balloon Coronary Angioplasty for In-Stent Restenosis A Case Report
    Wang, Wenjun
    Wang, Bailu
    Chen, Yuguo
    Wei, Shujian
    INTERNATIONAL HEART JOURNAL, 2021, 62 (01) : 171 - 174
  • [24] Comparison of the efficacy of balloon angioplasty or paclitaxel-coated balloon or stent implantation for in-stent restenosis based on analysis by optical coherence tomography
    Yamane, K.
    Hayashi, Y.
    Fujii, Y.
    Ueda, Y.
    Morita, Y.
    Miyake, Y.
    Fujiwara, M.
    Nagamoto, Y.
    Mito, S.
    Watari, Y.
    Tamekiyo, H.
    Okimoto, T.
    Muraoka, Y.
    EUROPEAN HEART JOURNAL, 2018, 39 : 528 - 528
  • [25] Drug-coated balloon in superficial femoral artery in-stent restenosis
    Gerardi, Donato
    Alfani, Arturo
    Tesorio, Tullio
    Cioppa, Angelo
    Esposito, Giovanni
    Stabile, Eugenio
    POSTEPY W KARDIOLOGII INTERWENCYJNEJ, 2018, 14 (01): : 9 - 14
  • [26] In-stent tissue characteristics detected by optical coherence tomography may affect re-restenosis after cutting balloon angioplasty for in-stent restenosis
    Taniike, M.
    Nishino, M.
    Yoshimura, T.
    Nakamura, D.
    Makino, N.
    Egami, Y.
    Shutta, R.
    Morita, H.
    Tanouchi, J.
    Yamada, Y.
    EUROPEAN HEART JOURNAL, 2013, 34 : 219 - 219
  • [27] Drug-Coated Balloons for In-Stent Restenosis
    Kereiakes, Dean J.
    Kandzari, David E.
    Zidar, James P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (11) : 1391 - 1392
  • [28] Drug-coated balloon angioplasty versus drug-eluting stent implantation in ACS patients with different angiographic patterns of in-stent restenosis
    Xie, Haifang
    Qiu, Miaohan
    Li, Xinyan
    Xiao, Yao
    Mu, Yanyan
    Wang, Geng
    Han, Yaling
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2024, 415
  • [29] A drug-coated balloon effectively treated in-stent restenosis due to a stent fracture
    Oba, Yusuke
    Funayama, Hiroshi
    Fukutomi, Motoki
    Kario, Kazuomi
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2018, 34 (02): : 169 - 170
  • [30] A drug-coated balloon effectively treated in-stent restenosis due to a stent fracture
    Yusuke Oba
    Hiroshi Funayama
    Motoki Fukutomi
    Kazuomi Kario
    The International Journal of Cardiovascular Imaging, 2018, 34 : 169 - 170